Amprius Technologies (NYSE:AMPX) Shares Down 5.5% - Should You Sell?

Amprius Technologies logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Amprius shares fell 5.5% to $6.73, with trading volume 15% above its daily average.
  • Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $20.50; B. Riley lowered its target from $22 to $16 while retaining a Buy rating.
  • Quarterly results were mixed: Amprius reported a $0.02-per-share loss, missing estimates by $0.01, while revenue of $39.15 million exceeded forecasts of $35.80 million.
  • MarketBeat previews the top five stocks to own by December 1st.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report)'s stock price fell 5.5% on Tuesday. The company traded as low as $6.51 and last traded at $6.7280. Approximately 8,625,885 shares changed hands during trading, an increase of 15% from the average daily volume of 7,475,424 shares. The stock had previously closed at $7.12.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on AMPX shares. UBS Group restated an "outperform" rating on shares of Amprius Technologies in a research report on Friday, November 6th. B. Riley Financial cut their price objective on shares of Amprius Technologies from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Thursday, November 12th. HC Wainwright reiterated a "buy" rating on shares of Amprius Technologies in a research note on Thursday, November 12th. Zacks Research upgraded shares of Amprius Technologies from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 4th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Amprius Technologies in a report on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $20.50.

Get Our Latest Stock Report on Amprius Technologies

Amprius Technologies Price Performance

The firm's 50-day simple moving average is $8.95 and its 200 day simple moving average is $13.16. The firm has a market capitalization of $952.89 million, a price-to-earnings ratio of -24.03 and a beta of 2.36.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its earnings results on Tuesday, November 10th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.01). Amprius Technologies had a negative net margin of 29.94% and a negative return on equity of 12.01%. The business had revenue of $39.15 million during the quarter, compared to analyst estimates of $35.80 million. During the same period in the prior year, the business posted ($0.03) EPS. As a group, research analysts predict that Amprius Technologies, Inc. will post -0.08 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Thomas M. Stepien sold 8,000 shares of the company's stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $10.03, for a total transaction of $80,240.00. Following the completion of the transaction, the chief executive officer directly owned 594,096 shares in the company, valued at $5,958,782.88. This represents a 1.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CTO Constantin Stefan sold 29,681 shares of the company's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $10.34, for a total transaction of $306,901.54. Following the transaction, the chief technology officer owned 771,629 shares of the company's stock, valued at approximately $7,978,643.86. This represents a 3.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 123,311 shares of company stock worth $1,272,556 in the last ninety days. 5.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Amprius Technologies

Several hedge funds have recently modified their holdings of AMPX. Sylebra Capital LLC bought a new position in Amprius Technologies in the third quarter valued at about $4,540,000. Cetera Investment Advisers grew its holdings in shares of Amprius Technologies by 10.1% during the third quarter. Cetera Investment Advisers now owns 33,732 shares of the company's stock worth $327,000 after purchasing an additional 3,081 shares during the last quarter. Elequin Capital LP increased its stake in shares of Amprius Technologies by 45,184.4% in the third quarter. Elequin Capital LP now owns 81,512 shares of the company's stock valued at $789,000 after buying an additional 81,332 shares during the period. Flputnam Investment Management Co. increased its stake in shares of Amprius Technologies by 28.9% in the third quarter. Flputnam Investment Management Co. now owns 82,999 shares of the company's stock valued at $803,000 after buying an additional 18,588 shares during the period. Finally, FORA Capital LLC acquired a new position in shares of Amprius Technologies in the third quarter valued at approximately $104,000. Institutional investors and hedge funds own 5.04% of the company's stock.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc. develops and manufactures lithium-ion batteries designed to provide high energy density and power. Its battery technology uses silicon-based anodes, an alternative to the graphite anodes commonly used in conventional lithium-ion cells. The company's products are designed for applications where low weight and high performance are important, including electric aviation, drones, aerospace, defense and other mobility markets. Amprius offers silicon-anode cells for customers developing these systems.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines